Gemini Clinical Trial Site — Abilene, Texas

Gemini Clinical Trial Site is a clinical research site located in Abilene, Texas, United States 79606.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Gemini Clinical Trial Site has participated in 1 clinical trials.

Therapeutic areas: Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration.

Sponsors: Gemini Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Abilene

Browse all research sites in Texas · View every site in Abilene

• Retina Research Institute of Texas
• Hendrick Medical Center
• Texas Oncology West Texas
• Texas Oncology-Abilene
• Retina Res Institute of Texas
• Texas Cancer Center/Abilene
• Texas Cancer Center
• Hendrick Cancer Center
• Hendrick Health
• West Texas Retina Consultants P.A.
• Velocity Clinical Research Abilene
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gemini Clinical Trial Site?

Gemini Clinical Trial Site has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gemini Clinical Trial Site conducted?

Gemini Clinical Trial Site has 1 clinical trials on record. Their work covers Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration.

Is Gemini Clinical Trial Site accredited by Crixeo Clinical Trials?

Gemini Clinical Trial Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gemini Clinical Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.